Skip to main content
CUREXO, INC. logo

CUREXO, INC. — Investor Relations & Filings

Ticker · 060280 ISIN · KR7060280005 KO Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2024-03-05 Proxy Solicitation & In…
Country KR South Korea
Listing KO 060280

About CUREXO, INC.

https://www.curexo.com/eng/

CUREXO, INC. is a medical robotics company specializing in the development, manufacturing, and commercialization of advanced robotic systems for surgical and rehabilitation applications. The company's product portfolio includes the 'CUVIS-joint' for artificial knee replacement surgery, the 'CUVIS-spine' for guiding spinal procedures, and the 'MORNINGWALK' for gait rehabilitation therapy. CUREXO focuses on providing innovative medical solutions to address conditions such as degenerative arthritis and spinal disorders, aiming to improve surgical precision and patient recovery outcomes through its proprietary robotic technologies.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and proxy solicitation details. While it includes financial statements, these are provided as part of the proxy materials for shareholder review ahead of the meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2024-03-05 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients due to resignations and exercises. This type of disclosure regarding capital structure and equity-based compensation is classified as a Regulatory Filing (RNS) as it does not fit into specific categories like Director's Dealing (which is for personal trades) or Share Issue (which is for new capital issuance).
2024-02-02 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Curexo. It details the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and appointment of audit committee members. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and request their participation/votes.
2024-02-02 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the total number of shares granted due to employee departures and exercises. This type of disclosure regarding stock-based compensation and capital structure changes falls under the category of regulatory filings for corporate actions that do not fit into specific categories like M&A or dividends, and is best classified as a general regulatory filing.
2024-02-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Curexo) announcing a significant change in financial results (revenue or profit/loss structure exceeding 30%). This is a standard 'Earnings Release' (ER) format used in the Korean market (DART system) to provide preliminary financial highlights before the final audited annual report is published. It details revenue, operating profit, and net income, along with the reasons for the changes, fitting the definition of an Earnings Release. FY 2023
2024-02-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders'. It details the share ownership and changes in holdings for a specific individual (Kim Seong-myeon, an executive at CUREXO). This type of filing is a standard regulatory requirement for insider trading and ownership reporting, which corresponds to the 'Director's Dealing' category.
2024-01-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.